Average Co-Inventor Count = 1.91
ph-index = 19
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Eli Lilly and Company (106 from 4,443 patents)
2. Lilly Industries, Inc. (2 from 158 patents)
3. Eli Lilly Company (1 from 10 patents)
109 patents:
1. 7501441 - Naphthyl compounds, intermediates, processes, compositions, and methods
2. RE39049 - Methods for inhibiting bone loss
3. RE38968 - Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
4. 6703407 - Benzofuran compounds, compositions, and methods
5. 6437137 - Naphthyl compounds, intermediates, processes, compositions, and methods
6. 6432983 - Benzothiophene compounds intermediates processes and methods of use
7. 6432982 - Benzothiophenes, and formulations and methods using same
8. 6410565 - &agr;1-adrenergic receptor antagonists
9. 6410564 - Naphthyl compounds, intermediates, processes, compositions, and methods
10. 6407243 - Benzofuran compounds, compositions, and methods
11. 6403615 - 2-Aryl-3-aroylbenzo {b} thiophenes useful for the treatment of estrogen deprivation syndrome
12. 6399634 - Benzothiophene compounds, compositions, and methods
13. 6395769 - 2-arylbenzo[b]thiophenes useful for the treatment of estrogen deprivation syndrome
14. 6274601 - Methods of inhibiting ulcerative mucositis
15. 6258826 - Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome